The CFO & EVP, Corp. Dev. of Cambrex Corp (CBM) is Selling Shares


Today, the CFO & EVP, Corp. Dev. of Cambrex Corp (CBM), Gregory Sargen, sold shares of CBM for $217.3K.

In addition to Gregory Sargen, one other CBM executive reported Sell trades in the last month.

See today’s analyst top recommended stocks >>

CBM’s market cap is $1.27B and the company has a P/E ratio of 13.74. Currently, Cambrex Corp has an average volume of 762.2K.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts